Advances in Neuroblastoma Research

Medicine & Life Sciences

1. Neuroblastoma 100%
2. Plasminogen Activators 90%
3. Urokinase-Type Plasminogen Activator 86%
4. Neoplasms 24%
5. Monoclonal Antibodies 14%
6. Animal Models 13%
7. Urokinase Plasminogen Activator Receptors 13%
8. Pediatrics 12%
9. Therapeutics 10%
10. Validation Studies 10%
11. Combination Drug Therapy 9%
12. Biological Products 9%
13. Acute Myeloid Leukemia 9%
14. Pancreatic Neoplasms 9%
15. Glioma 8%
16. Ovarian Neoplasms 8%
17. Colonic Neoplasms 8%
18. In Vitro Techniques 8%
19. Melanoma 7%
20. Pharmaceutical Preparations 7%
21. Prostatic Neoplasms 7%
22. Cause of Death 7%
23. Lung Neoplasms 7%
24. Cell Death 7%
25. Cell Proliferation 6%
26. Clinical Trials 6%
27. Breast Neoplasms 6%
28. Antigens 6%
29. Neoplasm Metastasis 5%
30. Cell Line 5%
31. Drug Therapy 5%
32. Antibodies 5%